Cited by 925Parkinson's Disease Mechanisms and TreatmentsAlzheimer's disease research and treatmentsNuclear Receptors and Signaling

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

Open access

Holmqvist, Staffan, Chutna, Oldriska, Bousset, Luc, Aldrin-Kirk, Patrick, Li, Wen, Björklund, Tomas, Wang, Zhan-You, Roybon, Laurent, Melki, Ronald, Li, Jia-Yi·2014·Acta Neuropathologica

DOI 10.1007/s00401-014-1343-6

Open this paper in CoChat — free account

Abstract

The cellular hallmarks of Parkinson's disease (PD) are the loss of nigral dopaminergic neurons and the formation of α-synuclein-enriched Lewy bodies and Lewy neurites in the remaining neurons. Based on the topographic distribution of Lewy bodies established after autopsy of brains from PD patients, Braak and coworkers hypothesized that Lewy pathology primes in the enteric nervous system and spreads to the brain, suggesting an active retrograde transport of α-synuclein (the key protein component in Lewy bodies), via the vagal nerve. This hypothesis, however, has not been tested experimentally thus far. Here, we use a human PD brain lysate containing different forms of α-synuclein (monomeric, oligomeric and fibrillar), and recombinant α-synuclein in an in vivo animal model to test this hypothesis. We demonstrate that α-synuclein present in the human PD brain lysate and distinct recombinant α-synuclein forms are transported via the vagal nerve and reach the dorsal motor nucleus of the vagus in the brainstem in a time-dependent manner after injection into the intestinal wall. Using live cell imaging in a differentiated neuroblastoma cell line, we determine that both slow and fast components of axonal transport are involved in the transport of aggregated α-synuclein. In conclusion, we here provide the first experimental evidence that different α-synuclein forms can propagate from the gut to the brain, and that microtubule-associated transport is involved in the translocation of aggregated α-synuclein in neurons.

Integrity signals

Registry

Crossref · 10.1007/s00401-014-1343-6

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Microtubules as a target for anticancer drugs
Jordan, M. A., & Wilson, L. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1317 · Cited by 4,000
Mobility measurement by analysis of fluorescence photobleaching recovery kinetics
Axelrod, D., Koppel, D. E., Schlessinger, J., Elson, E. L., & Webb, W. W. (1976) · Biophysical Journal · doi:10.1016/s0006-3495(76)85755-4 · Cited by 2,717
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O’Brien, P., Trojanowski, J. Q., & Lee, V. M.-Y. (2012) · Science · doi:10.1126/science.1227157 · Cited by 2,563
Lewy bodies in grafted neurons in subjects with Parkinson's disease suggest host-to-graft disease propagation
Li, J.-Y., Englund, E., Holton, J. L., Soulet, D., Hagell, P., Lees, A. J., Lashley, T., Quinn, N. P., Rehncrona, S., Björklund, A., et al. (2008) · Nature Medicine · doi:10.1038/nm1746 · Cited by 1,845
Self-citation
Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease
Kordower, J. H., Chu, Y., Hauser, R. A., Freeman, T. B., & Olanow, C. W. (2008) · Nature Medicine · doi:10.1038/nm1747 · Cited by 1,722
Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
Braak, H., R�b, U., Gai, W. P., & Del Tredici, K. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0808-2 · Cited by 1,683
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Desplats, P., Lee, H.-J., Bae, E.-J., Patrick, C., Rockenstein, E., Crews, L., Spencer, B., Masliah, E., & Lee, S.-J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903691106 · Cited by 1,485
In vivo demonstration that α-synuclein oligomers are toxic
Winner, B., Jappelli, R., Maji, S. K., Desplats, P. A., Boyer, L., Aigner, S., Hetzer, C., Loher, T., Vilar, M., Campioni, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1100976108 · Cited by 1,463

Show all 51 references

Sorted by citations

Items 401–500 of 925

Seeding Propensity and Characteristics of Pathogenic αSyn Assemblies in Formalin-Fixed Human Tissue from the Enteric Nervous System, Olfactory Bulb, and Brainstem in Cases Staged for Parkinson’s Disease
Fenyi, A., Duyckaerts, C. J., Bousset, L., Braak, H., Tredici, K. D., Melki, R., & on behalf of the Brainbank Neuro-CEB Neuropathology Network (2021) · Cells · doi:10.3390/cells10010139 · Cited by 31
Self-citation
Vagal cross-sectional area correlates with parasympathetic dysfunction in Parkinson's disease
Huckemann, S., Mueller, K., Averdunk, P., Kuhn, E. M., Hilker, L., Kools, S., Scholz, L., Bulut, Y., Brünger, J., Fiegert, S., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcad006 · Cited by 29
Differences in the gut microbiome across typical ageing and in Parkinson's disease
Nuzum, N. D., Szymlek‐Gay, E. A., Loke, S., Dawson, S. L., Teo, W., Hendy, A. M., Loughman, A., & Macpherson, H. (2023) · Neuropharmacology · doi:10.1016/j.neuropharm.2023.109566 · Cited by 32
From Skin and Gut to the Brain: The Infectious Journey of the Human Commensal Fungus Malassezia and Its Neurological Consequences
Naik, B., Sasikumar, J., & Das, S. P. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04270-w · Cited by 29
Microbiome-based therapeutics for Parkinson's disease
Hamilton, A. M., Krout, I. N., White, A. C., & Sampson, T. R. (2024) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00462 · Cited by 31
Leucine-rich repeat kinase-2 (LRRK2) modulates paraquat-induced inflammatory sickness and stress phenotype
membership, C., Rudyk, C., Dwyer, Z., & Hayley, S. P. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1483-7 · Cited by 29
Propagation of Pathological α-Synuclein from the Urogenital Tract to the Brain Initiates MSA-like Syndrome
Ding, X., Zhou, L., Jiang, X., Liu, H., Yao, J., Zhang, R., Liang, D., Wang, F., Ma, M., Tang, B., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101166 · Cited by 29
Gut microbiota, pathogenic proteins and neurodegenerative diseases
Wei, W., Wang, S., Xu, C., Zhou, X., Lian, X., He, L., & Li, K. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.959856 · Cited by 30
Changes in the sympathetic innervation of the gut in rotenone treated mice as possible early biomarker for Parkinson’s disease
Arnhold, M., Dening, Y., Chopin, M., Arévalo, E., Schwarz, M., Reichmann, H., Gille, G., Funk, R. H. W., & Pan-Montojo, F. J. (2016) · Clinical Autonomic Research · doi:10.1007/s10286-016-0358-6 · Cited by 29
Methods for detecting toxic α-synuclein species as a biomarker for Parkinson’s disease
O’Hara, D. M., Kalia, S. K., & Kalia, L. V. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2019.1711359 · Cited by 29
From Synaptic Protein to Prion: The Long and Controversial Journey of α-Synuclein
Heras‐Garvin, A., & Stefanova, N. (2020) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2020.584536 · Cited by 31
Parkinson's Disease and the Gut: Models of an Emerging Relationship
Bindas, A. J., Kulkarni, S., Koppes, R. A., & Koppes, A. N. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.03.071 · Cited by 27
The link between the gut microbiota and Parkinson’s Disease: A systematic mechanism review with focus on α-synuclein transport
Nielsen, S. D., Pearson, N. M., & Seidler, K. (2021) · Brain Research · doi:10.1016/j.brainres.2021.147609 · Cited by 29
Environmental neurotoxic pesticide exposure induces gut inflammation and enteric neuronal degeneration by impairing enteric glial mitochondrial function in pesticide models of Parkinson’s disease: Potential relevance to gut-brain axis inflammation in Parkinson’s disease pathogenesis
Palanisamy, B. N., Sarkar, S., Malovic, E., Samidurai, M., Charli, A., Zenitsky, G. D., Jin, H., Anantharam, V., Kanthasamy, A., & Kanthasamy, A. G. (2022) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2022.106225 · Cited by 29
Alpha-Synuclein Strain Variability in Body-First and Brain-First Synucleinopathies
Just, M. K., Gram, H., Theologidis, V., Jensen, P. H., Nilsson, K. P. R., Lindgren, M., Knudsen, K., Borghammer, P., & Berge, N. V. D. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.907293 · Cited by 32
PARK7/DJ-1 as a Therapeutic Target in Gut-Brain Axis Diseases
Pap, D., Veres-Székely, A., Szebeni, B., & Vannay, Á. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23126626 · Cited by 30
The role of LRRK2 in the periphery: link with Parkinson's disease and inflammatory diseases
Tsafaras, G., & Baekelandt, V. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105806 · Cited by 28
Parkinson’s Disease and Alpha-Synucleinopathies: from Arising Pathways to Therapeutic Challenge
Miraglia, F., Betti, L., Palego, L., & Giannaccini, G. (2015) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/1871524915666150421114338 · Cited by 29
Targeting α‐Synuclein as a therapy for Parkinson's disease: The battle begins
Olanow, C. W., & Kordower, J. H. (2017) · Movement Disorders · doi:10.1002/mds.26935 · Cited by 28
ATH434 Reduces α‐Synuclein‐Related Neurodegeneration in a Murine Model of Multiple System Atrophy
Heras‐Garvin, A., Refolo, V., Schmidt, C., Malfertheiner, K., Wenning, G. K., BRADBURY, M. J., Stamler, D. A., & Stefanova, N. (2021) · Movement Disorders · doi:10.1002/mds.28714 · Cited by 28
Drosophila as a Model for Microbiota Studies of Neurodegeneration
Kitani‐Morii, F., Friedland, R. P., Yoshida, H., & Mizuno, T. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215031 · Cited by 31
NMR analysis of the CSF and plasma metabolome of rigorously matched amyotrophic lateral sclerosis, Parkinson’s disease and control subjects
Wu, J., Wuolikainen, A., Trupp, M., Jonsson, P., Marklund, S. L., Andersen, P. M., Forsgren, L., & Öhman, A. (2016) · Metabolomics · doi:10.1007/s11306-016-1041-6 · Cited by 27
Parkinson’s Disease and the Gut: Future Perspectives for Early Diagnosis
Harsányiová, J., Buday, T., & Trancikova, A. K. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.00626 · Cited by 29
Buty and the beast: the complex role of butyrate in Parkinson’s disease
Elford, J. D., Becht, N. N., Garssen, J., Kraneveld, A. D., & Perez‐Pardo, P. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1388401 · Cited by 28
How the gut microbiota impacts neurodegenerative diseases by modulating CNS immune cells
Schaible, P., Henschel, J., & Erny, D. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03371-0 · Cited by 32
In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons
Fouka, M., Mavroeidi, P., Tsaka, G., & Xilouri, M. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.559791 · Cited by 27
Mutations in GBA and LRRK2 Are Not Associated with Increased Inflammatory Markers
Thaler, A., Omer, N., Giladi, N., Gurevich, T., Bar‐Shira, A., Gana‐Weisz, M., Goldstein, O., Kestenbaum, M., Shirvan, J. C., Cedarbaum, J. M., et al. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212624 · Cited by 27
Rat Models of Vocal Deficits in Parkinson’s Disease
Krasko, M. N., Hoffmeister, J. D., Schaen‐Heacock, N. E., Welsch, J. M., Kelm‐Nelson, C. A., & Ciucci, M. R. (2021) · Brain Sciences · doi:10.3390/brainsci11070925 · Cited by 26
Fecal Microbiota Transplantation as a Tool for Therapeutic Modulation of Non-gastrointestinal Disorders
Lipták, R., Gromová, B., & Gardlík, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.665520 · Cited by 26
Tracking Innate Immune Activation in a Mouse Model of Parkinson’s Disease Using TREM1 and TSPO PET Tracers
Lucot, K. L., Stevens, M. Y., Bonham, T. A., Azevedo, E. C., Chaney, A. M., Webber, E. D., Jain, P., Klockow, J., Jackson, I. M., Carlson, M. L., et al. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263039 · Cited by 26
Update to the Treatment of Parkinson’s Disease Based on the Gut-Brain Axis Mechanism
Sun, X., Li, X., Wang, Z., & Xie, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.878239 · Cited by 29
Self-citation
The relationship between Parkinson’s disease and gastrointestinal diseases
Zeng, J., Wang, X., Pan, F., & Mao, Z. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.955919 · Cited by 26
Manipulation of the diet–microbiota–brain axis in Alzheimer’s disease
Lee, D. D., Lee, V. M. ‐., & Hur, S. K. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1042865 · Cited by 27
Probiotics for constipation in Parkinson’s: A systematic review and meta-analysis of randomized controlled trials
Yin, S., & Zhu, F. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1038928 · Cited by 28
Towards early detection of neurodegenerative diseases: A gut feeling
Makdissi, S., Parsons, B., & Cara, F. D. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1087091 · Cited by 28
Gut–Brain Axis in Focus: Polyphenols, Microbiota, and Their Influence on α-Synuclein in Parkinson’s Disease
Riegelman, E., Xue, K. S., Wang, J.-S., & Tang, L. (2024) · Nutrients · doi:10.3390/nu16132041 · Cited by 29
Prion-like properties of disease-relevant proteins in amyotrophic lateral sclerosis
Bräuer, S., Zimyanin, V. L., & Hermann, A. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1851-y · Cited by 29
Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson’s disease patients
Recasens, A., Carballo‐Carbajal, I., Parent, A., Bové, J., Gelpí, E., TOLOSA, E. S., & Vila, M. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0509-1 · Cited by 27
Effects of vagus nerve stimulation are mediated in part by TrkB in a parkinson’s disease model
Farrand, A. Q., Helke, K. L., Aponte-Cofresí, L., Gooz, M. B., Gregory, R. A., Hinson, V. K., & Boger, H. A. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112080 · Cited by 26
Changes of gut microbiota in patients at different phases of stroke
Cui, W., Xu, L., Huang, L., Tian, Y., Yang, Y., Li, Y., & Yu, Q. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14271 · Cited by 25
Microbial amyloids in neurodegenerative amyloid diseases
Sampson, T. R. (2023) · FEBS Journal · doi:10.1111/febs.17023 · Cited by 25
Postmortem Studies of Fetal Grafts in Parkinson’s Disease: What Lessons Have We Learned?
Li, J., & Li, W. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.666675 · Cited by 26
Self-citation
Open questions on the nature of Parkinson’s disease: from triggers to spreading pathology
Mou, L., Ding, W., & Fernández-Fúnez, P. (2019) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2019-106210 · Cited by 28
Molecular Communication Between Neuronal Networks and Intestinal Epithelial Cells in Gut Inflammation and Parkinson’s Disease
Drobny, A., Ngo, P. A., Neurath, M. F., Zunke, F., & López-Posadas, R. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.655123 · Cited by 24
P. mirabilis-derived pore-forming haemolysin, HpmA drives intestinal alpha-synuclein aggregation in a mouse model of neurodegeneration
Huh, E., Choi, J. G., Choi, Y., Ju, I. G., Kim, B., Shin, Y.-J., An, J. M., Park, M. G., Yim, S. V., Chung, S. J., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104887 · Cited by 24
Low dose DMSO treatment induces oligomerization and accelerates aggregation of α-synuclein
Reimer, L., Haikal, C., Gram, H., Theologidis, V., Kovács, G. E., Ruesink, H., Baun, A. M., Nielsen, J., Otzen, D. E., Li, J., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-07706-2 · Cited by 22
Self-citation
Implication of Paraprobiotics in Age-Associated Gut Dysbiosis and Neurodegenerative Diseases
Rahman, Z., & Dandekar, M. P. (2022) · NeuroMolecular Medicine · doi:10.1007/s12017-022-08722-1 · Cited by 25
Discovery of a Gut Bacterial Metabolic Pathway that Drives α-Synuclein Aggregation
Ortiz de Ora, L., Balsamo, J. M., Uyeda, K. S., & Bess, E. N. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00095 · Cited by 24
Vacuolar Protein Sorting Genes in Parkinson's Disease: A Re-appraisal of Mutations Detection Rate and Neurobiology of Disease
Gambardella, S., Biagioni, F., Ferese, R., Busceti, C. L., Frati, A., Novelli, G., Ruggieri, S. A., & Fornai, F. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00532 · Cited by 24
Parkinson’s disease; the hibernating spore hypothesis
Berstad, K., & Berstad, J. R. (2017) · Medical Hypotheses · doi:10.1016/j.mehy.2017.05.022 · Cited by 25
PD-like pathogenesis induced by intestinal exposure to microplastics: An in vivo study of animal models to a public health survey
Bai, H., Gu, H., Zhou, W., Shi, G., Yan, J., Su, Y., Li, W., Li, Y., Zhong, C., Zhao, N., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.136974 · Cited by 26
Self-citation
Vertebrate food products as a potential source of prion-like α-synuclein
Killinger, B. A., & Labrie, V. (2017) · npj Parkinson s Disease · doi:10.1038/s41531-017-0035-z · Cited by 23
The enteric nervous system in PD: gateway, bystander victim, or source of solutions
Shannon, K. M., & Berghe, P. V. (2018) · Cell and Tissue Research · doi:10.1007/s00441-018-2856-4 · Cited by 23
High-resolution ultrasound changes of the vagus nerve in idiopathic Parkinson’s disease (IPD): a possible additional index of disease
Sartucci, F., Bocci, T., Santin, M., Bongioanni, P., & Orlandi, G. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05183-5 · Cited by 23
Vagus nerve ultrasonography in Parkinson's disease: A systematic review and meta-analysis
Abdelnaby, R., Elsayed, M., Mohamed, K. A., Dardeer, K. T., Sonbol, Y. T., Elgenidy, A., Barakat, M. H., Alwerdani, M. M., & Maier, A. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102835 · Cited by 23
Exploring the multifactorial aspects of Gut Microbiome in Parkinson’s Disease
Pavan, S., Prabhu, A., Gorthi, S. P., Das, B., Mutreja, A., Shetty, V., Ramamurthy, T., & Ballal, M. (2022) · Folia Microbiologica · doi:10.1007/s12223-022-00977-2 · Cited by 25
Ghrelin Bridges DMV Neuropathology and GI Dysfunction in the Early Stages of Parkinson's Disease
Liu, Y., Wang, W., Song, N., Jiao, L., Jia, F., Du, X., Chen, X., Yan, C., Jiao, J., Jiao, Q., et al. (2022) · Advanced Science · doi:10.1002/advs.202203020 · Cited by 23
Gut-Brain Axis Deregulation and Its Possible Contribution to Neurodegenerative Disorders
Villavicencio-Tejo, F., Olesen, M. A., Navarro, L., Calisto, N., Iribarren, C., GARCÍA, K. P., Corsini, G., & Quintanilla, R. A. (2023) · Neurotoxicity Research · doi:10.1007/s12640-023-00681-0 · Cited by 24
Lysosomal storage, impaired autophagy and innate immunity in Gaucher and Parkinson's diseases: insights for drug discovery
Hull, A. J., Atilano, M. L., Gergi, L., & Kinghorn, K. J. (2024) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0381 · Cited by 24
A neuroscience perspective of the gut theory of Parkinson's disease
Smith, L. M., & Parr‐Brownlie, L. C. (2018) · European Journal of Neuroscience · doi:10.1111/ejn.13869 · Cited by 25
Immunology of West Nile Virus Infection and the Role of Alpha-Synuclein as a Viral Restriction Factor
Lesteberg, K. E., & Beckham, J. D. (2018) · Viral Immunology · doi:10.1089/vim.2018.0075 · Cited by 23
Overview of the Gut–Brain Axis: From Gut to Brain and Back Again
Post, Z., Manfready, R. A., & Keshavarzian, A. (2023) · Seminars in Neurology · doi:10.1055/s-0043-1771464 · Cited by 25
Phytonutrients and their neuroprotective role in brain disorders
Adhikary, K., Ganguly, K., Sarkar, R., Abubakar, M., Banerjee, P., & Karak, P. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1607330 · Cited by 26
Movement of prion‐like α‐synuclein along the gut–brain axis in Parkinson's disease: A potential target of curcumin treatment
Chetty, D., Abrahams, S., van Coller, R., Carr, J. A., Kenyon, C. P., & Bardien, S. (2021) · European Journal of Neuroscience · doi:10.1111/ejn.15324 · Cited by 22
Helicobacter hepaticus augmentation triggers Dopaminergic degeneration and motor disorders in mice with Parkinson’s disease
Ahn, E. H., Liu, X., Alam, A. M., Kang, S. S., & Ye, K. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01910-2 · Cited by 22
Addition of α-synuclein aggregates to the intestinal environment recapitulates Parkinsonian symptoms in model systems
Yang, Z.-X., Zhang, Y., Wang, Q., Zhang, L., Liu, Y., Zhang, Y., Ren, Y., Zhou, C., Gao, H.-W., Zhang, N.-X., et al. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01150-2 · Cited by 23
The gut microbiome: an important role in neurodegenerative diseases and their therapeutic advances
Li, S., Zhao, L., Xiao, J., Guo, Y., Fu, R., Zhang, Y., & Xu, S. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04853-6 · Cited by 23
Gut–brain axis and environmental factors in Parkinson’s disease: bidirectional link between disease onset and progression
Park, S. J., Kim, K. W., & Lee, E. J. (2024) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-00994 · Cited by 27
Bottoms up: the role of gut microbiota in brain health
Radisavljevic, N., Cirstea, M. S., & Finlay, B. B. (2018) · Environmental Microbiology · doi:10.1111/1462-2920.14506 · Cited by 24
Investigation of nerve pathways mediating colorectal dysfunction in Parkinson’s disease model produced by lesion of nigrostriatal dopaminergic neurons
Chai, X., Diwakarla, S., Pustovit, R. V., McQuade, R. M., Natale, M. R. D., Ermine, C. M., Parish, C. L., Finkelstein, D. I., & Furness, J. B. (2020) · Neurogastroenterology & Motility · doi:10.1111/nmo.13893 · Cited by 21
Distribution of α-synuclein in normal human jejunum and its relations with the chemosensory and neuroendocrine system
Casini, A., Mancinelli, R., Mammola, C. L., Pannarale, L., Chirletti, P., Onori, P., & Vaccaro, R. (2021) · European Journal of Histochemistry · doi:10.4081/ejh.2021.3310 · Cited by 23
The Bacterial Amyloids Phenol Soluble Modulins from Staphylococcus aureus Catalyze Alpha-Synuclein Aggregation
Haikal, C., Ortigosa-Pascual, L., Najarzadeh, Z., Bernfur, K., Svanbergsson, A., Otzen, D. E., Linse, S. S., & Li, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111594 · Cited by 21
Self-citation
Assembly of α-synuclein and neurodegeneration in the central nervous system of heterozygous M83 mice following the peripheral administration of α-synuclein seeds
Macdonald, J. A., Chen, J. L., Masuda‐Suzukake, M., Schweighauser, M., Jaunmuktane, Z., Warner, T. T., Holton, J. L., Grossman, A., Berks, R., Lavenir, I., et al. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01291-7 · Cited by 22
To the Gut Microbiome and Beyond: The Brain-First or Body-First Hypothesis in Parkinson’s Disease
Nuzum, N. D., Loughman, A., Szymlek‐Gay, E. A., Teo, W., Hendy, A. M., & Macpherson, H. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.791213 · Cited by 21
Intrastriatal injection of Parkinson’s disease intestine and vagus lysates initiates α-synucleinopathy in rat brain
Yang, Z., Wang, Y., Wei, M., Li, S., Jia, C., Cheng, C., Al‐Nusaif, M., Zhang, J., Liu, C., & Le, W. (2023) · Cell Death and Disease · doi:10.1038/s41419-022-05531-z · Cited by 25
Potential of Akkermansia muciniphila and its outer membrane proteins as therapeutic targets for neuropsychological diseases
Zhang, F., & Wang, D. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1191445 · Cited by 23
Biochemical analysis of α-synuclein extracted from control and Parkinson’s disease colonic biopsies
Corbillé, A.-G., Preterre, C., Rolli‐Derkinderen, M., Coron, E., Neunlist, M., Lebouvier, T., & Derkinderen, P. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.01.050 · Cited by 23
Association of Parkinson’s disease and treatment with aminosalicylates in inflammatory bowel disease: a cross-sectional study in a Spain drug dispensation records
Ríos, J. P., Madrid-Navarro, C. J., Navarro, M., Tapia, M. J. C., Vera, M. J. P., Arillo, V. M. C., García, M. R. G., Mínguez‐Castellanos, A., & Sevilla, F. E. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-025574 · Cited by 21
Impairment of Nrf2- and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson’s Disease
Sampath, C., Kalpana, R., Ansah, T.-A., Charlton, C. G., Hale, A., Channon, K. M., Srinivasan, S., & Gangula, P. R. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05693-5 · Cited by 21
Alpha-synuclein alters the faecal viromes of rats in a gut-initiated model of Parkinson’s disease
Stockdale, S. R., Draper, L. A., O’Donovan, S. M., Barton, W., O’Sullivan, Ó., Volpicelli‐Daley, L. A., Sullivan, A. M., O’Neill, C., & Hill, C. (2021) · Communications Biology · doi:10.1038/s42003-021-02666-1 · Cited by 20
The Gut Microbiome and Alzheimer’s Disease: A Growing Relationship
Zerdan, M. B., Hebbo, E., Hijazi, A., Gemayel, M. E., Nasr, J., Nasr, D., Yaghi, M., Bouferraa, Y., & Nagarajan, A. (2022) · Current Alzheimer Research · doi:10.2174/1567205020666221227090125 · Cited by 22
The Brain, the Eating Plate, and the Gut Microbiome: Partners in Migraine Pathogenesis
Gazerani, P., Papetti, L., Dalkara, T., Cook, C. L., Webster, C., & Bai, J. (2024) · Nutrients · doi:10.3390/nu16142222 · Cited by 22
Peripheral huntingtin silencing does not ameliorate central signs of disease in the B6.HttQ111/+ mouse model of Huntington’s disease
Coffey, S. R., Bragg, R. M., Minnig, S., Ament, S. A., Cantle, J. P., Glickenhaus, A., Shelnut, D., Carrillo, J. M., Shuttleworth, D. D., Rodier, J.-A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175968 · Cited by 17
Neuroprotection and immunomodulation of progesterone in the gut of a mouse model of Parkinson's disease
Jarras, H., Bourque, M., Poirier, A.-A., Morissette, M., Coulombe, K., Paolo, T. D., & Soulet, D. (2019) · Journal of Neuroendocrinology · doi:10.1111/jne.12782 · Cited by 20
The Emerging Role of Human Gut Bacteria Extracellular Vesicles in Mental Disorders and Developing New Pharmaceuticals
Louka, E., & Koumandou, V. L. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46050286 · Cited by 20
Vagus nerve and brain–gut communication in neurodegenerative diseases: Mechanism and therapeutic perspectives
Luo, S., Pan, M., Fu, G., Meng, X., Zhao, Z., Yu, H., Yue, G.-X., & Lei, T. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107974 · Cited by 19
What Is Our Understanding of the Influence of Gut Microbiota on the Pathophysiology of Parkinson’s Disease?
Hill, A. E., Wade‐Martins, R., & Burnet, P. W. J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.708587 · Cited by 19
Neuro-Immunity and Gut Dysbiosis Drive Parkinson’s Disease-Induced Pain
Roversi, K., Callai-Silva, N., Roversi, K., Griffith, M., Boutopoulos, C., Prediger, R. D., & Talbot, S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.759679 · Cited by 19
The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson’s disease
Shi, J., Wang, Y., Chen, D., Xu, X., Li, W., Li, K., He, J., Su, W., & Luo, Q. (2023) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-023-12410-w · Cited by 19
Self-citation
Safety and feasibility of faecal microbiota transplantation for patients with Parkinson’s disease: a protocol for a self-controlled interventional donor-FMT pilot study
Vendrik, K. E. W., Chernova, V. O., Kuijper, E. J., Terveer, E. M., van Hilten, J. J., & Contarino, M. F. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-071766 · Cited by 27
The gastrointestinal tract and Parkinson’s disease
Higinbotham, A. S., & Kilbane, C. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1158986 · Cited by 22
FGF2 Affects Parkinson’s Disease-Associated Molecular Networks Through Exosomal Rab8b/Rab31
Kumar, R., Donakonda, S., Müller, S. A., Bötzel, K., Höglinger, G. U., & Koeglsperger, T. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.572058 · Cited by 19
Transport of cargo from periphery to brain by circulating monocytes
Cintron, A. F., Dalal, N. V., Dooyema, J. M., Betarbet, R. S., & Walker, L. C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.06.047 · Cited by 19
Convergence of longevity and immunity: lessons from animal models
Xia, J., Gravato-Nobre, M. J., & Ligoxygakis, P. (2019) · Biogerontology · doi:10.1007/s10522-019-09801-w · Cited by 17
The potential of natural products to inhibit abnormal aggregation of α-Synuclein in the treatment of Parkinson’s disease
Yang, K., Lv, Z., Wen, Z., Lai, G., Zheng, C., Qi, F., Zhao, C., Hu, K., Chen, X., Fu, F., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1468850 · Cited by 19
Self-citation
The Role of the Gastrointestinal Microbiota in Parkinson’s Disease
Gabrielli, M., Verme, L. Z. D., Zocco, M. A., Nista, E. C., Ojetti, V., & Gasbarrini, A. (2024) · Biomolecules · doi:10.3390/biom15010026 · Cited by 19
Gene Therapy to Modulate Alpha-Synuclein in Synucleinopathies
Sandoval, I. M., Marmion, D. J., Meyers, K. T., & Manfredsson, F. P. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212679 · Cited by 20
GRID2 Aberration Leads to Disturbance in Neuroactive Ligand-Receptor Interaction via Affecting the Species Richness and Composition of the Gut Microbes
Huang, S., Zhang, C., Xie, X., Zhu, Y., Song, Q., Ye, L., & Hu, Y. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.09.006 · Cited by 18
Overexpression-Induced α-Synuclein Brain Spreading
Pinto‐Costa, R., Harbachova, E. L., Vitola, P. L., & Monte, D. A. D. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01332-6 · Cited by 17
Neuroprotective Effects of Bifidobacterium animalis subsp. lactis NJ241 in a Mouse Model of Parkinson’s Disease: Implications for Gut Microbiota and PGC-1α
Dong, Y., Qi, Y., Chen, J., Han, S., Su, W., Ma, X., Yu, Y., & Wang, Y. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04038-2 · Cited by 18

Authors: Holmqvist, S., Chutna, O., Bousset, L., Aldrin-Kirk, P., Li, W., Björklund, T., Wang, Z.-Y., Roybon, L., Melki, R., & Li, J.-Y.
Affiliations: Lund University (SE)
Centre National de la Recherche Scientifique (FR)
Northeastern University (CN)
ORCID: Holmqvist, Staffan
Bousset, Luc
Aldrin-Kirk, Patrick
Li, Wen
Björklund, Tomas
Wang, Zhan-You
Roybon, Laurent
Melki, Ronald
Venue: Acta Neuropathologica
Publisher: Springer Science and Business Media LLC
Published: 2014-10-09
Volume: 128
Issue: 6
Pages: 805-820
ISSN: 0001-6322 (ISSN-L)
1432-0533
DOI: 10.1007/s00401-014-1343-6
OpenAlex: W1995281235
Cited by: 925
References: 51
Citations by year: 2026: 47 · 2025: 67 · 2024: 73 · 2023: 67 · 2022: 110 · 2021: 132 · 2020: 102 · 2019: 107 · 2018: 75 · 2017: 59 · 2016: 43 · 2015: 38 · 2014: 3
FWCI: 30.94
Type: journal article
Language: en
Open access: green
lup.lub.lu.se
Licence: other-oa
www.springer.com/tdm (tdm)
Locations: Acta Neuropathologica (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Lund University Publications (Lund University) (submittedVersion, other-oa)
Funders: Agence Nationale de la Recherche (ANR-11-BSV8-0021)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
Keywords: Parkinson's disease, alpha-synuclein, Lewy bodies, gut-brain axis, vagus nerve, retrograde transport, enteric nervous system, dorsal motor nucleus of the vagus, axonal transport, alpha-synuclein aggregation, rat model
MeSH terms: Animals, Axonal Transport, Brain, Disease Models, Animal, Humans, Parkinson Disease, Recombinant Proteins, Vagus Nerve, Rats, Sprague-Dawley, Disease Progression, Gastrointestinal Tract, Cell Line, Tumor, alpha-Synuclein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks